271 related articles for article (PubMed ID: 34411919)
1. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
3. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer activity of Chaga mushroom (
Abugomaa A; Elbadawy M; Ishihara Y; Yamamoto H; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
Front Pharmacol; 2023; 14():1159516. PubMed ID: 37153767
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386
[TBL] [Abstract][Full Text] [Related]
6. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
Cho YH; Ro EJ; Yoon JS; Mizutani T; Kang DW; Park JC; Il Kim T; Clevers H; Choi KY
Nat Commun; 2020 Oct; 11(1):5321. PubMed ID: 33087710
[TBL] [Abstract][Full Text] [Related]
7. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
8. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
[TBL] [Abstract][Full Text] [Related]
9. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
10. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
[TBL] [Abstract][Full Text] [Related]
11. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
Feng Y; Gao S; Gao Y; Wang X; Chen Z
Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077
[TBL] [Abstract][Full Text] [Related]
12. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.
Shakibaei M; Buhrmann C; Kraehe P; Shayan P; Lueders C; Goel A
PLoS One; 2014; 9(1):e85397. PubMed ID: 24404205
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells.
Li G; Fang S; Shao X; Li Y; Tong Q; Kong B; Chen L; Wang Y; Yang J; Yu H; Xie X; Zhang J
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572508
[TBL] [Abstract][Full Text] [Related]
14. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
Zheng X; Yang X; Lin J; Song F; Shao Y
Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
16. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
[TBL] [Abstract][Full Text] [Related]
17. Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?
Brockmueller A; Samuel SM; Mazurakova A; Büsselberg D; Kubatka P; Shakibaei M
Life Sci; 2023 Apr; 318():121504. PubMed ID: 36813082
[TBL] [Abstract][Full Text] [Related]
18. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
[TBL] [Abstract][Full Text] [Related]
19. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
